Top

Published in:

01-12-2005

Development and regulation of monoclonal antibody products: Challenges and opportunities

Authors: Wendy C. Weinberg, Michelle R. Frazier-Jessen, Wen Jin Wu, Andrea Weir, Melanie Hartsough, Patricia Keegan, Chana Fuchs

Published in: Cancer and Metastasis Reviews | Issue 4/2005

Title: Development and regulation of monoclonal antibody products: Challenges and opportunities
Authors: Wendy C. Weinberg
Michelle R. Frazier-Jessen
Wen Jin Wu
Andrea Weir
Melanie Hartsough
Patricia Keegan
Chana Fuchs
Publication date: 01-12-2005
Publisher: Kluwer Academic Publishers
Published in: Cancer and Metastasis Reviews / Issue 4/2005
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-005-6196-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2005

Designing antibodies for oncology

Preface

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies

Volume Table of Contents

Editorial

Antibody-based therapeutics: Focus on prostate cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer